Bausch+Lomb Investor Conference Presentation Deck
R&D Delivering Opportunities in High Growth, High Margin Categories ¹
Expected to Launch More than 15 Products in 2023
2023
Launches
BAUSCH + LOMB
Vision Care/
Consumer
Growing market
share with new
products, line extensions
and geo-expansion
Ophthalmic Pharmaceuticals
Launching high-margin
pharmaceutical products
Surgical
Shift surgical portfolio
to premium categories
M&A
Supported by
M & A
1. See Slide 1 for further information on forward-looking statements.
2. Launched in 2022 with continued growth in 2023 and beyond.
BAUSCH LONG
LUMIFY
Se
Lumify®
geo-expansion
XIPERE™²
en Vista®
Premium.
IOL Expansion
Teneo™M Excimer
Laser for Refractive
Surgery (US)
LUXSMART
CMART
400.00
T
VIZULTA
Prof
Lux Premium
IOL Expansion
true
BAUSCH+LOMB
IFRETE PY
Channel
ARISE
ORTHO-K SYSTEM
VYZULTAⓇ
geo-expansion
CON
Bio
true
INFUSE
e eyeTELLIGENCE
eye Telligence ™
digital ecosystem
true
Daily SiHy Multifocal
Daily SiHy geo-expansion
Bio
true
3D Microscope
Post IPO, completed 5 acquisitions/licensing transactions to enhance pipeline
NOV03
Minimally Invasive
Micro Sclerostomy
("MIMSⓇ")
14View entire presentation